DOCSLIB.ORG

Nasal Hyperreactivity and Inflammation in Perennial Allergic Rhinitis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Nasal Hyperreactivity and Inflammation in Perennial Allergic Rhinitis Nasal hyperreactivity and inflammation in perennial allergic rhinitis Nasale hyperreactiviteit en ontsteking in chronische allergische rhinitis In 't Veld, Catharina & Garrelds, Ingrid Martine. Nasal hyperreactivity and inflanunation in perennial allergy I C. in 't Veld & I.M. Garrelds. Thesis Erasmus University Rotterdam. - With ref. - With summary in Dutch. Subject headings: nasal hyperreactivity / inflammation / perennial allergic rhinitis. © C. in 't Veld & I.M. Garrelds 1995 All rights reserved, Save exceptions stated by the law, no part of this publication may be reproduced, stored in a retrieval system of any nature, or transmitted in any form or by means, electronic, mechanical, photocopying, recording or otherwise, included a complete or partial transcription, without the prior written permission of the authors, Nasal hyperreactivity and inflammation in perennial allergic rhinitis Nasale hyperreactiviteit en ontsteking in chronische allergische rhinitis PROEFSCHRlFT Tel' verkrijging van de graad van doctor aan de Erasmus Universiteit Rotterdam op gezag van de rector magnificus Prof. Dr. P.W.C. Akkermans M.A. en volgens besluit van het college voor promoties. De openbare verdediging zal plaatsvinden op woensdag 22 november 1995 om 13.45 Ullt'. door CATHARINA IN 'T VELD geboren te Rotterdam De openbare verdediging zal plaatsvinden op woensdag 22 november 1995 om 15.00 Ullt'. door INGRID MARTINE GARRELDS geboren te Dordrecht PROMOTIE COMMISSIE: C. IN 'T VELD: PROMOTOR: Prof. Dr. C.D.A. Verwoerd OVERIGE LEDEN: Prof. Dr. P.R. Saxena Prof. Dr. F.P. Nijkamp Prof. Dr. J.G.R. de Monchy CO-PROMOTOR: Dr. R. Gerth van Wijk I.M. GARRELDS: PROMOTOR: Prof. Dr. P.R. Saxena OVERIGE LEDEN: Prof. Dr. C.D.A. Verwoerd Prof. Dr. F.P. Nijkamp Prof. Dr. J.G.R. de Monchy CO-PROMOTOR: Dr. F.J. Zijlstra Acknowledgement - Financial supp0l1 by the Netherlands Asthma Foundation (research grant 92,74); Janssen-Cilag B.Y.; Glaxo B.Y.; Pharmachcmie B.V" Haarlem; ARTU Biologicals N.V.; ASTA Medica B.V.; A.C.M. Ooms Allergie B.V.; Bolidt Kunststof­ toepassing B.V.; ALK Benelux B.V.; Schering-Plough B.V.; UCB Pharma B.V.; Cara C'nir; Bio-RAD for this study and the pUblication of this thesis is gratefully acknowledged. vaal' Erik en Jeroen Contents Contents vii Preface xi PART ONE: General introduction Chapter 1. Allergic rhinitis 3 c. de Graa/-il1" Veld, l Ai GOl'l'elds 1.1 Historical review of allergy 3 1.2 Allergic rhinitis 4 1.2.1 Epidemiology 4 1.2.2 Clinical aspects of allergic rhinitis 4 1.2.3 Impact on daily activities and quality of life 4 1.3 Reactions of nasal mucosa on allergen exposure 5 1.3.1 Immediate allergic reaction 6 1.3.2 Late allergic reaetion 6 1.3.3 Nasal priming 6 1.4 Allergen-induced nasal hyperrcactivity 7 1.5 Allergic rhinitis. A model to study airway inflammation 9 Chapter 2. Allergic inflammation II I.M. Garre/ds, C. de Graaf-in't Veld 2.l Introduction II 2.2 Cells in allergic rhinitis II 2.2.1 Primary effector cells II Mast cells II Antigen-presenting cells 12 Epithelial cells 13 2.2.2 Secondary effcclor cells 14 Basophils 14 Eosinophils 15 Neulrophils 16 Monocytes/macrophages 17 Lymphocytes 17 Platelets 19 2.3 Products of allergic inflammation 20 Histamine 20 Tryptase 21 Eicosanoids 22 Platelet activating factor 24 Eosinophil-derived granule proteins 25 Cytokines 26 Nitric oxide 28 2.4 Concluding remarks 29 vii Chapter 3. Aim of the study 31 PART TWO: Hypel'l'eactivity and inflammation 33 Chapter 4. Nasal responsiveness to allergen and histamine are associated 35 in patients with perennial allergic rhinitis c. de Graafill', Veld, 1.M. Garrelds, A. rl~ vall Toorenenbergen, R. Gerth van Wijk Chapter 5. Relationships between nasal hyperreactivity, mediators and eosinophils 45 in paticnts with perennial allergic rhinitis and controls c. de Graafin't Veld, I.M. Garrelds, S. Koenders, R. Gerth vall fVijk PART THREE: Thel'apeutic inten'ention 53 Chapter 6. Glucocorticosteroid intervention 55 Chapter 7. Effect of intranasal fluticasone propionate on the immediate and 57 late allergic nasal reaction and nasal hyperreactivity in patients with a house dust mite allergy c. de Graaf-in" Veld, I.M. Garrelds, A.P.H. Jansen, A.IV. van Toorenenbergen, P.G.H. Mlilder, J Meellwis, R. Gerth van H'ijk Chapter 8. Effect of fluticasone propionate aqueous nasal spray treatment on 67 platelet activating factor and eicosanoid production by nasal mucosa in patients with a hOllse dust mite allergy I.M. Garrelds, C. de Graaf-in't Vehl, A.P.!f. Jansen, R. Gel'th van Wijk, F.J. Zijlstra Chapter 9. Interleukin-5 and eosinophil cationic protein in nasal lavages of 75 rhinitis patients J.A!. Garrelds, C. de Graafin't Vehl, AI-A Nahor;, B.B. Vargaflig, R. Gerth van Wijk, F.J. Zijlstra Chapter 10. Nitric oxide metabolites in nasal lavage fluid of patients with 85 hOllse dust mite aJIergy U.l. Gal'relds, J.G.c. vall Amsterdam, C. de Graafin't Vehl, R. Gerth van Wijk, F.J. Zijlstra Chapter 11. The reduction of symptoms to the corticoid fluticasone propionate of 93 patients with perennial allergic rhinitis is not associated with glucoc0l1icoid receptor binding characteristics of peripheral blood mononuclear cells I.M. Gan'e/ds, C. de Graafin" Veld, P.G.!/. Alulder, R. Gerth van Wijk, F.J. Zijlstra Chapter 12. Antihistaminic intervention 103 viii Contents Chapter 13. Effect of topicallevocabastine on nasal response to allergen challenge 105 and nasal hyperreactivity in perclUlial rhinitis C. de Graafill't Veld, l.M Garrelds, A. W. van Toorenenbergen, P.G.H. Mllider, R. Gerth van Wijk, J.P.J. Boegheim Chapter 14. Selective effect of levocabastine on histamine receptor and 115 histamine release from human leukocytes and guinea-pig isolated tissue 1.M. Garrelds, C. de Graafin't Veld, A.H~ van Toorenenbergen, R. Gerth van Wijk, J.P.J. Boegheim, P.R. Sm:ena, F.J. Zijlslra PART FOUR: Hyperreactivity and quality of life 129 Chapter 15. The relationships between nasal hyperreactivity, quality of life 131 and nasal symptoms in perennial allergic rhinitis c. de Graafin't Veld, S. Koenders, l.A!. Garrelds, R. Gerth van Wijk PART FIVE: General discussion and summary 139 Chapter 16. General discussion 141 Chapter 17. Summary 149 Samenvatting 152 References 156 Abbreviations 186 Dankwoord 189 Curriculum vitae 190 Publications 191 ix Preface Allergic rhinitis is a conunon disease resulting in a high morbidity. It is defined as an inflammation of the nasal mucosa and is characterised by symptoms such as itchy nose, sneezing, rhinorrhoea and nasal blockage. Repetitive allergen exposure gives rise to increased sensitivity to allergens (priming) and nonspecific stimuli. This nonspecific nasal hyperreactivily can be measured by history and by nasal challenge tests with methacholine or histamine. However, the pathogenesis of nasal hyperreactivity is still not clear. In asthmatic patients bronchial hyperreactivity seems to be associated with the latc phase response and allergic inflammation, suggesting that inflammation is involved in the pathogenesis of hyperreactivity. In analogy with the bronchial situation these associations were also studied in the nose. Until now, most studies investigating the relationship between nasal response to allergen and nasal hyperreactivity have been performed in patients with pollinosis. In these studies no relationship could be found between nasal hyperreactivity, nasal priming, the late phase response and nasal inflammation, Only a few studies have been performed in patients allcrgic to house dust mites (BDM). In this subgroup it has becn demonstrated that pre-existent nasal hyperreactivity can predict nasal response to allergen challenge, a finding more in agreement with the lower airways. In this thesis we further want to investigate the relationship between nasal hyperreactivity, nasal response to allergen and nasal inflammation in perennial rhinitis. Hereto, we evaluated the effects of therapeutic intervention on nasal response to allergen and hyperreactivity and data obtained during the placebo treatment. Nasal response to HDM challenge was monitored by symptoms and mediators in nasal lavage fluid. Allergen-induced nasal hyperreactivity was determined 24 hours later by nasal challenge with histamine or methacholine. It is expected that non-specific nasal hyperreactivity is particularly important in patients with perennial allergic rhinitis, since they are continuously exposed to allergen. However, the importance of routine histamine challenges in daily practice is not clear. Hereto, we studied nasal response to histamine and daily nasal symptoms. Inflammatory mediators in lavage fluid and eosinophils in cytospins were also determined in order to evaluate the involvement of inflammation in the ongoing allergic reaction. In addition, we investigated the impact of rhinitis symptoms on day-to-day life. By means of a rhinitis quality of life (QOL) questiOlUlaire, the relationship between nasal response to histamine, QOL and daily nasal symptoms was estimated in patients allergic to HDM. Part one presents the definitions and clinical aspects of allergic rhinitis (chapter one), the cells and mediators involved in the allergic reaction (chapter two) and the aims of the study (chapter 3). In part two the relationship between nasal hyperreactivity and inflammation is studied. Chapter 4 describes a nasal challenge study in patients with perennial rhinitis. Inflammatory mediators and nasal hyperreactivity were compared between patients with an early and late phase response and individuals expressing an isolated early response only. In chapter 5, inflammatory mediators in nasal lavage, eosinophils in nasal blUshes and responsiveness to histamine were studied in non-challenged patients with perennial rhinitis xi Preface and healthy subjects. Part three concerns the therapeutic intervention on nasal response to allergen challenge and hyperreactivity with a c0l1icosteroid (fluticasonc propionate) and an antihistamine (levocabastine). In chapter 7-10 the effect of two weeks topical fluticasone propionate on the immediate and late nasal symptoms, inflammatory mediators and nasal response to histamine is described.
Load more

Recommended publications
  • Allergens Immunoglobulin E (Ige) Antibodies
    Allergens − Immunoglobulin E (IgE) Antibodies Single Allergen IgE Antibody This test is principally useful to confirm the allergen specificity in patients with clinically documented allergic disease. Therefore, requests for these tests should be made after a careful and comprehensive medical history is taken. Utilized in this manner, a single allergen immunoglobulin E (IgE) antibody test is cost-effective. A positive result may indicate that allergic signs and symptoms are caused by exposure to the specific allergen. Multi-allergen IgE Antibodies Profile Tests A number of related allergens are grouped together for ordering convenience. Each is tested individually and reported. Sample volume requirements are the same as if the tests were ordered individually. Panel Tests A pooled allergen reagent is used for each panel; therefore, the panel is reported with a single qualitative class result and concentration. The multi-allergen IgE antibody panel, combined with measurement of IgE in serum, is an appropriate first-order test for allergic disease. Positive results indicate the possibility of allergic disease induced by one or more allergens present in the multi-allergen panel. Negative results may rule out allergy, except in rare cases of allergic disease induced by exposure to a single allergen. Panel testing requires less specimen volume and less cost for ruling out allergic response; however, individual (single) allergen responses cannot be identified. In cases of a positive panel test, follow-up testing must be performed to differentiate between individual allergens in the panel. Note: Only 1 result is generated for each panel. Panels may be ordered with or without concurrent measurement of total IgE.
    [Show full text]
  • ALLERGIC REACTIONS/ANAPHYLAXIS Connie J
    Northwest Community EMS System Paramedic Education Program ALLERGIC REACTIONS/ANAPHYLAXIS Connie J. Mattera, M.S., R.N., EMT-P Reading assignments Text-Vol.1 pp. 235, 1272-1276 SOP: Allergic Reactions/ Anaphylactic Shock Assumed knowledge: Drugs: Epinephrine 1:1,000, 1:10,000; albuterol, ipratropium, dopamine, glucagon KNOWLEDGE OBJECTIVES Upon reading the assigned text assignments and completion of the class and homework questions, each participant will independently do the following with at least an 80% degree of accuracy and no critical errors: 1. Define allergic reaction. 2. Describe the incidence, morbidity and mortality of allergic reactions and anaphylaxis. 3. Identify risk factors that predispose a patient to anaphylaxis. 4. Explain the physiology of the immune system following exposure to an allergen including activation of histamine receptors and the formation of antibodies. 5. Discuss the pathophysiology of allergic reactions and anaphylaxis. 6. Describe the common modes by which allergens enter the body. 7. Compare and contrast natural and acquired and active vs. passive immunity. 8. Identify antigens most frequently associated with anaphylaxis. 9. Differentiate the clinical presentation and severity of risk for a mild, moderate and severe allergic reaction with an emphasis on recognizing an anaphylactic reaction. 10. Integrate the pathophysiologic principles of anaphylaxis with treatment priorities. 11. Sequence care per SOP for patients with mild, moderate and severe allergic reactions. CJM: S14 NWC EMSS Paramedic Education Program ALLERGIC REACTIONS/ANAPHYLAXIS Connie J. Mattera, M.S., R.N., EMT-P I. Immune system A. Principal body system involved in allergic reactions. Others include the cutaneous, cardiovascular, respiratory, nervous, and gastrointestinal systems.
    [Show full text]
  • Neoantigen Prevents Allergic Sensitization to a Initial High-Dose Nasal Allergen Exposure
    Initial High-Dose Nasal Allergen Exposure Prevents Allergic Sensitization to a Neoantigen This information is current as Marc A. Riedl, Elliot M. Landaw, Andrew Saxon and David of September 28, 2021. Diaz-Sanchez J Immunol 2005; 174:7440-7445; ; doi: 10.4049/jimmunol.174.11.7440 http://www.jimmunol.org/content/174/11/7440 Downloaded from References This article cites 45 articles, 15 of which you can access for free at: http://www.jimmunol.org/content/174/11/7440.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Initial High-Dose Nasal Allergen Exposure Prevents Allergic Sensitization to a Neoantigen1 Marc A. Riedl,2* Elliot M. Landaw,† Andrew Saxon,* and David Diaz-Sanchez* Primary allergic sensitization—IgE formation after Ag exposure—is fundamental in the development of allergic respiratory disease.
    [Show full text]
  • Allergy Markers in Respiratory Epidemiology
    Copyright #ERS Journals Ltd 2001 Eur Respir J 2001; 17: 773±790 European Respiratory Journal Printed in UK ± all rights reserved ISSN 0903-1936 SERIES "CONTRIBUTIONS FROM THE EUROPEAN RESPIRATORY MONOGRAPHS" Edited by M. Decramer and A. Rossi Number 1 in thisSeries Allergy markers in respiratory epidemiology S. Baldacci*, E. Omenaas#, M.P. Oryszczyn} Allergy markers in respiratory epidemiology. S. Baldacci. #ERS Journals Ltd 2001. *Institute of Clinical Physiology, Pisa, ABSTRACT: Assessing allergy by measurement of serum immunoglobulin Ig) E Italy. #Dept of Thoracic Medicine, University of Bergen, Bergen, Norw- antibodies is fast and safe to perform. Serum antibodies can preferably be assessed in } patients with dermatitis and in those who regularly use antihistamines and other ay. INSERM U472, Villejuif, France. pharmacological agents that reduce skin sensitivity. Correspondence: S. Baldacci, Istituto di Skin tests represent the easiest tool to obtain quick and reliable information for the Fisiologia Clinica, CNR, Via Trieste diagnosis of respiratory allergic diseases. It is the technique more widely used, speci®c 41, 56126 Pisa, Italy. and reasonably sensitive for most applications as a marker of atopy. Fax: 39 50503596 Measurement of serum IgE antibodies and skin-prick testing may give complimentary information and can be applied in clinical and epidemiological settings. Keywords: Atopy, eosinophilia, epide- Peripheral blood eosinophilia is less used, but is important in clinical practice to miology, general population, immuno- demonstrate the allergic aetiology of disease, to monitor its clinical course and to globulin E, skin test reactivity address the choice of therapy. In epidemiology, hypereosinophilia seems to re¯ect an Received: December 11 2000 in¯ammatory reaction in the airways, which may be linked to obstructive air¯ow Accepted after revision December 15 limitation.
    [Show full text]
  • A Rationale for Targeting Sentinel Innate Immune Signaling of Group 1 House Dust Mite Allergens Th
    Molecular Pharmacology Fast Forward. Published on July 5, 2018 as DOI: 10.1124/mol.118.112730 This article has not been copyedited and formatted. The final version may differ from this version. MOL #112730 1 Title Page MiniReview for Molecular Pharmacology Allergen Delivery Inhibitors: A Rationale for Targeting Sentinel Innate Immune Signaling of Group 1 House Dust Mite Allergens Through Structure-Based Protease Inhibitor Design Downloaded from molpharm.aspetjournals.org Jihui Zhang, Jie Chen, Gary K Newton, Trevor R Perrior, Clive Robinson at ASPET Journals on September 26, 2021 Institute for Infection and Immunity, St George’s, University of London, Cranmer Terrace, London SW17 0RE, United Kingdom (JZ, JC, CR) State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P.R. China (JZ) Domainex Ltd, Chesterford Research Park, Little Chesterford, Saffron Walden, CB10 1XL, United Kingdom (GKN, TRP) Molecular Pharmacology Fast Forward. Published on July 5, 2018 as DOI: 10.1124/mol.118.112730 This article has not been copyedited and formatted. The final version may differ from this version. MOL #112730 2 Running Title Page Running Title: Allergen Delivery Inhibitors Correspondence: Professor Clive Robinson, Institute for Infection and Immunity, St George’s, University of London, SW17 0RE, UK c.robinson@sgul.ac.uk Downloaded from Number of pages: 68 (including references, tables and figures)(word count = 19,752) 26 (main text)(word count = 10,945) Number of Tables: 3 molpharm.aspetjournals.org
    [Show full text]
  • Lab Animal Allergies
    Volume 27 No. 5 2012 basophils. Since mast cells and basophils are his issue of the BRL Bulletin will discuss T abundant in the skin, conjunctiva, respiratory allergies due to exposure to laboratory animals. tract, and gastrointestinal tract, these areas are Laboratory animal allergy (LAA) is the most the sites for allergic reactions. In these areas, it is common medical condition that affects individuals the histamine released by the mast cells and who work with animals in the research basophils that causes the symptoms commonly environment. It has been estimated that 11 to 44% seen in allergic individuals, including constriction of individuals who work with laboratory animals will of airways, tissue edema, increased mucus develop an allergic condition to these animals. Of secretion, itching, and sneezing. Once a person those who develop allergies, four to 22% will is sensitized to an allergen, he/she will develop eventually develop occupation-related asthma, a allergic symptoms within 10-15 minutes of serious, life-long respiratory disease. In other subsequent exposure to that allergen. In addition words, more than one out of ten people who work to this early phase reaction, approximately half of with laboratory animals will develop allergic allergic individuals will also develop a late phase symptoms and of these individuals, at least one reaction three to four hours following exposure to out of twenty will develop asthma. It has been the allergen. This reaction typically reaches its reported that the prevalence of asthma maximum intensity four to eight hours following subsequent to LAA might be decreasing because exposure, and resolves after 12 to 14 hours.
    [Show full text]
  • Diseases of the Immune System 813
    Chapter 19 | Diseases of the Immune System 813 Chapter 19 Diseases of the Immune System Figure 19.1 Bee stings and other allergens can cause life-threatening, systemic allergic reactions. Sensitive individuals may need to carry an epinephrine auto-injector (e.g., EpiPen) in case of a sting. A bee-sting allergy is an example of an immune response that is harmful to the host rather than protective; epinephrine counteracts the severe drop in blood pressure that can result from the immune response. (credit right: modification of work by Carol Bleistine) Chapter Outline 19.1 Hypersensitivities 19.2 Autoimmune Disorders 19.3 Organ Transplantation and Rejection 19.4 Immunodeficiency 19.5 Cancer Immunobiology and Immunotherapy Introduction An allergic reaction is an immune response to a type of antigen called an allergen. Allergens can be found in many different items, from peanuts and insect stings to latex and some drugs. Unlike other kinds of antigens, allergens are not necessarily associated with pathogenic microbes, and many allergens provoke no immune response at all in most people. Allergic responses vary in severity. Some are mild and localized, like hay fever or hives, but others can result in systemic, life-threatening reactions. Anaphylaxis, for example, is a rapidly developing allergic reaction that can cause a dangerous drop in blood pressure and severe swelling of the throat that may close off the airway. Allergies are just one example of how the immune system—the system normally responsible for preventing disease—can actually cause or mediate disease symptoms. In this chapter, we will further explore allergies and other disorders of the immune system, including hypersensitivity reactions, autoimmune diseases, transplant rejection, and diseases associated with immunodeficiency.
    [Show full text]
  • How Allergies Work Allergies Work
    Howstuffworks "How Allergies Work" 8/20/02 8:46 AM Free Newsletter! • Suggestions!Click Here!• Win! • About HSW • Contact Us • Home Daily Stuff • Top 40 • What's New • HSW Store • Forums • Advertise! • Affiliate Search HowStuffWorks & the Web Click here to go back to the normal view! How Allergies Work by Steve Beach A properly functioning immune system is a well-trained and disciplined biological warfare unit for the Photo courtesy National Institute body. The immune of Allergy and Infectious Disease system is really quite (NIAID) amazing. It is able to An immune cell identify and destroy undergoing an allergic many foreign invaders. reaction The immune system can also identify cells that are infected internally with viruses, as well as many cells that are on their way to becoming tumors. It does all of this work so the body remains healthy. As amazing as the immune system is, it sometimes makes mistakes. Allergies are the result of a hypersensitive immune system. The allergic immune system misidentifies an otherwise innocuous substance as harmful, and then attacks the substance with a ferocity far greater than required. The problems this attack can cause range from mildly inconvenient and uncomfortable to the total failure of the organism the immune system is supposed to be protecting. In this edition of HowStuffWorks, we'll examine the most established school of thought on what makes up the condition referred to as an allergy. A defining premise of this school of thought is that allergic symptoms are always triggered by a http://www.howstuffworks.com/allergy.htm/printable Page 1 of 10 Howstuffworks "How Allergies Work" 8/20/02 8:46 AM protein.
    [Show full text]
  • Profiling the Extended Cleavage Specificity of the House Dust Mite Protease Allergens Der P 1, Der P 3 and Der P 6 for the Predi
    International Journal of Molecular Sciences Article Profiling the Extended Cleavage Specificity of the House Dust Mite Protease Allergens Der p 1, Der p 3 and Der p 6 for the Prediction of New Cell Surface Protein Substrates Alain Jacquet 1,† , Vincenzo Campisi 2,3,†, Martyna Szpakowska 2,†, Marie-Eve Dumez 2,3, Moreno Galleni 3 and Andy Chevigné 2,* 1 Faculty of Medicine, Division of Research Affairs, Chulalongkorn University, 10330 Bangkok, Thailand; alain.J@chula.ac.th 2 Department of Infection and Immunity, Luxembourg Institute of Health (LIH), 29, rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg; vcampisi@live.be (V.C.); martyna.szpakowska@lih.lu (M.S.); marie-eve.x.dumez@gsk.com (M.-E.D.) 3 Laboratoire des Macromolécules Biologiques, Centre for Protein Engineering (CIP), University of Liège, 4000 Liège, Belgium; mgalleni@ulg.ac.be * Correspondance: andy.chevigne@lih.lu; Tel.: +352-26-970-336; Fax: +352-26-970-390 † These authors contributed equally to this work. Received: 15 May 2017; Accepted: 21 June 2017; Published: 27 June 2017 Abstract: House dust mite (HDM) protease allergens, through cleavages of critical surface proteins, drastically influence the initiation of the Th2 type immune responses. However, few human protein substrates for HDM proteases have been identified so far, mainly by applying time-consuming target-specific individual studies. Therefore, the identification of substrate repertoires for HDM proteases would represent an unprecedented key step toward a better understanding of the mechanism of HDM allergic response. In this study, phage display screenings using totally or partially randomized nonameric peptide substrate libraries were performed to characterize the extended 0 substrate specificities (P5–P4 ) of the HDM proteases Der p 1, Der p 3 and Der p 6.
    [Show full text]
  • Ige and Drug Allergy: Antibody Recognition of 'Small' Molecules of Widely Varying Structures and Activities
    Antibodies 2014, 3, 56-91; doi:10.3390/antib3010056 OPEN ACCESS antibodies ISSN 2073-4468 www.mdpi.com/journal/antibodies Review IgE and Drug Allergy: Antibody Recognition of ‘Small’ Molecules of Widely Varying Structures and Activities Brian A. Baldo † Molecular Immunology Unit, Kolling Institute of Medical Research, Royal North Shore Hospital of Sydney, and Department of Medicine, University of Sydney, Sydney 2065, Australia; E-Mail: babaldo@iinet.net.au; Tel.: +61-2-9880-9757 † Author is retired. Formerly: Head of Molecular Immunology Unit. Received: 19 November 2013; in revised form: 19 December 2013 / Accepted: 18 January 2014 / Published: 22 January 2014 Abstract: The variety of chemically diverse pharmacologically-active compounds administered to patients is large and seemingly forever growing, and, with every new drug released and administered, there is always the potential of an allergic reaction. The most commonly occurring allergic responses to drugs are the type I, or immediate hypersensitivity reactions mediated by IgE antibodies. These reactions may affect a single organ, such as the nasopharynx (allergic rhinitis), eyes (conjunctivitis), mucosa of mouth/throat/tongue (angioedema), bronchopulmonary tissue (asthma), gastrointestinal tract (gastroenteritis) and skin (urticaria, eczema), or multiple organs (anaphylaxis), causing symptoms ranging from minor itching and inflammation to death. It seems that almost every drug is capable of causing an immediate reaction and it is unusual to find a drug that has not provoked an anaphylactic response in at least one patient. These facts alone indicate the extraordinary breadth of recognition of IgE antibodies for drugs ranging from relatively simple structures, for example, aspirin, to complex molecules, such as the macrolide antibiotics composed of a large macrocyclic ring with attached deoxy sugars.
    [Show full text]
  • Immunology of the Allergic Response 1
    9781405157209_4_001.qxd 4/1/08 20:03 Page 1 1 Immunology of the Allergic Response 9781405157209_4_001.qxd 4/1/08 20:03 Page 2 .. 9781405157209_4_001.qxd 4/1/08 20:03 Page 3 1 Allergy and Hypersensitivity: History and Concepts A. Barry Kay Summary The study of allergy (“allergology”) and hypersensitivity, and the associated allergic diseases, have their roots in the science of immunology but overlap with many disciplines including pharmacology, biochemistry, cell and molecular biology, and general pathology, particularly the study of inflammation. Allergic diseases involve many organs and tissues such as the upper and lower airways, the skin, and the gastrointestinal tract and therefore the history of relevant discoveries in the field are long and complex. This chapter gives only a brief account of the major milestones in the history of allergy and the concepts which have arisen from them. It deals mainly with discoveries in Fig. 1.1 A commemorative postage stamp to mark the discovery the 19th and early 20th century, particularly the events which of anaphylaxis by Charles R. Richet (1850–1935) and Paul J. Portier followed the description of anaphylaxis and culminated in the (1866–1962). discovery of IgE as the carrier of reaginic activity. An important conceptual landmark that coincided with the considerable foreign proteins to various species including dogs (Magendie increase in knowledge of immunologic aspects of hypersensitivity 1839), guinea pigs (Von Behring 1893, quoted in Becker 1999, was the Coombs and Gell classification of hypersensitivity p. 876) and rabbits (Flexner 1894, reviewed in Bulloch 1937). reactions in the 1960s. This classification is revisited and updated However it was not until the discovery of anaphylaxis by to take into account some newer finding on the initiation of the allergic response.
    [Show full text]
  • Allergens and Their Role in the Allergic Immune Response
    Thomas A. E. Platts-Mills Allergens and their role in the Judith A. Woodfolk allergic immune response Authors’ address Summary: Allergens are recognized as the proteins that induce immuno- 1 1 Thomas A. E. Platts-Mills , Judith A. Woodfolk globulin E (IgE) responses in humans. The proteins come from a range of 1 Asthma and Allergic Diseases Center, University of Virginia sources and, not surprisingly, have many different biological functions. Health System, Charlottesville, VA, USA. However, the delivery of allergens to the nose is exclusively on particles, which carry a range of molecules in addition to the protein allergens. Correspondence to: These molecules include pathogen-associated molecular patterns (PAMPs) Thomas A. E. Platts-Mills that can alter the response. Although the response to allergens is charac- Allergy Division, PO Box 801355 terized by IgE antibodies, it also includes other isotypes (IgG, IgA, and University of Virginia Health System IgG4), as well as T cells. The challenge is to identify the characteristics of Charlottesville, VA 22908-1355, USA these exposures that favor the production of this form of response. The Tel.: +1 434 924 5917 primary features of the exposure appear to be the delivery in particles, Fax: +1 434 924 5779 such as pollen grains or mite feces, containing both proteins and PAMPs, e-mail: tap2z@virginia.edu but with overall low dose. Within this model, there is a simple direct relationship between the dose of exposure to mite or grass pollen and the Acknowledgements prevalence of IgE responses. By contrast, the highest levels of exposure to The authors declare no conflicts of interest.
    [Show full text]